A new study reveals that nicotine-activated lung cells emit exosomes carrying serotransferrin, which can disturb neuronal iron homeostasis and trigger processes associated with neurodegeneration
The connection between smoking and cognitive decline has long been suggested by population studies, including work from 2011 that found heavy smoking in midlife more than doubled the later-life risk of dementia, including Alzheimer’s and vascular dementia. Until now, explanations focused mainly on reduced oxygen delivery and vascular damage from chronic tobacco exposure.
However, newer laboratory findings show that the lung can actively send biochemical signals to the brain, creating a plausible mechanistic bridge that links inhaled nicotine to long-term neuronal changes. This research reframes the lung as an organ capable of influencing brain health via cellular messaging.
The University of Chicago team published their results in Science Advances on April 8, 2026 (Thakur et al., DOI: 10.1126/sciadv.ady2696). Using human-derived models, researchers found that a rare population of airway cells responds to nicotine by releasing abundant exosomes enriched in a protein called serotransferrin.
Those particles travel along physiological routes that ultimately perturb iron handling in neurons, producing molecular signatures commonly seen in neurodegenerative disorders. To study this, the group created laboratory versions of these scarce cells to produce enough material for rigorous experiments.
From airway sensors to neuronal signaling
At the center of this discovery are pulmonary neuroendocrine cells, a tiny subset of lung cells that act as both sensory and secretory elements. The researchers describe pulmonary neuroendocrine cells (PNECs) as hybrid cells that speak chemical and electrical languages, yet comprise less than 1% of lung tissue and are therefore difficult to study directly. By differentiating human pluripotent stem cells into induced PNECs (iPNECs), the team exposed these cells to nicotine and observed a surge of exosome release. Those exosomes, carrying serotransferrin, are capable of altering systemic iron cues and initiating downstream responses transmitted to the brain, plausibly via autonomic pathways such as the vagus nerve.
Iron imbalance and cellular stress in the brain
When neuronal iron regulation is disturbed, a cascade of harmful processes can follow. The study links PNEC-derived exosomes to iron dyshomeostasis in neurons, which promotes oxidative stress, mitochondrial dysfunction, and increased expression of proteins like α-synuclein—molecular features associated with neurodegenerative disorders. The team also observed markers consistent with ferroptosis, an iron-dependent form of programmed cell death that prior research has connected to Alzheimer’s and Parkinson’s pathologies. While these cellular changes are compelling, the authors emphasize that demonstrating a direct causal chain from smoking to clinical dementia will require much more longitudinal and translational work.
Modeling rare lung cells in the lab
One technical advance that made the study possible was the generation of large numbers of iPNECs from human pluripotent stem cells, overcoming the practical barrier posed by the rarity of native PNECs. This in vitro approach allowed detailed analysis of exosome composition and function under controlled nicotine exposure. The iPNEC-derived exosomes were found to be unusually rich in serotransferrin, suggesting that tobacco-derived nicotine can cause the lung to emit molecular instructions that mislead systemic iron regulation. These experiments link a single environmental exposure to measurable biochemical changes with neuronal consequences.
Potential interventions and future directions
Looking ahead, the authors outline several translational avenues, including investigating whether inhibiting exosome release or neutralizing their cargo could blunt the lung-to-brain signaling pathway. Such strategies remain speculative and years from clinical testing, but they represent a novel class of interventions that target inter-organ communication rather than the brain alone. The study highlights the need for additional animal and human research to test whether blocking PNEC-derived exosomes reduces neurodegenerative markers, and whether similar mechanisms operate in people who smoke, vape, or use nicotine therapeutics.
In sum, the work by Thakur, Kui Zhang, Abhimanyu Thakur, Joyce Chen, and colleagues (published April 8, 2026, in Science Advances) expands understanding of how inhaled nicotine can influence distant organs. By revealing a lung-brain axis mediated by PNEC-derived exosomes and serotransferrin-driven iron disruption, the study offers a mechanistic explanation that complements epidemiological links between smoking and dementia. For public health, the findings reinforce the long-term cognitive risks associated with tobacco and nicotine exposure while pointing to new biological targets for preventing smoke-related neurodegeneration.
